ML20045F030: Difference between revisions

From kanterella
Jump to navigation Jump to search
(StriderTol Bot insert)
 
(StriderTol Bot change)
 
Line 2: Line 2:
| number = ML20045F030
| number = ML20045F030
| issue date = 06/30/1993
| issue date = 06/30/1993
| title = Forwards Roche Biomedical Labs 930602 Ltr Reporting Unsatisfactory Performance Testing Result,As Part of fitness-for-duty Program.Blind Urine Sample Tested Positive for Amphetamine & Reported Negative by Lab
| title = Forwards Roche Biomedical Labs Reporting Unsatisfactory Performance Testing Result,As Part of fitness-for-duty Program.Blind Urine Sample Tested Positive for Amphetamine & Reported Negative by Lab
| author name = Hill L
| author name = Hill L
| author affiliation = LONG ISLAND POWER AUTHORITY
| author affiliation = LONG ISLAND POWER AUTHORITY
Line 11: Line 11:
| contact person =  
| contact person =  
| document report number = LRM-93-068, LRM-93-68, NUDOCS 9307060334
| document report number = LRM-93-068, LRM-93-68, NUDOCS 9307060334
| title reference date = 06-02-1993
| document type = CORRESPONDENCE-LETTERS, INCOMING CORRESPONDENCE
| document type = CORRESPONDENCE-LETTERS, INCOMING CORRESPONDENCE
| page count = 2
| page count = 2
Line 17: Line 18:
=Text=
=Text=
{{#Wiki_filter:.
{{#Wiki_filter:.
    ~'
~'
Long                   Shoreham Nuclear Power Station                         l Island                 P.O. Box 628                                           I gg           Power Authority North Country Road Wading River, N.Y.11792 N f/r                                                                                      l LRM-93-068         !
Long Shoreham Nuclear Power Station l
i June 30, 1993 U. S. Nuclear Regulatory Commission Document Control Desk                                                                 ~r Washington, D. C.         20555                                                       ,
Island P.O. Box 628 I
                                                                                                    }
gg Power North Country Road N f/r Authority Wading River, N.Y.11792 l
F Attention:       Office of NRR Division of Reactor Inspection and Safeguards                       ,
LRM-93-068 i
June 30, 1993 U.
S. Nuclear Regulatory Commission
~r Document Control Desk Washington, D.
C.
20555
}
F Attention:
Office of NRR Division of Reactor Inspection and Safeguards


==Subject:==
==Subject:==
Fitness for Duty Program-Shoreham Nuclear Power Station Unsatisfactory Performance Testing Result                           *
Fitness for Duty Program-Shoreham Nuclear Power Station Unsatisfactory Performance Testing Result


==Reference:==
==Reference:==
Letter Roche Biomedical Laboratories (JP Watson) to Dr. K. Goetz dated 6/2/93
Letter Roche Biomedical Laboratories (JP Watson) to Dr.
K. Goetz dated 6/2/93


==Dear Sir:==
==Dear Sir:==
 
This notification is being sent in accordance with
This notification         is being sent in accordance with         10CFR26, Appendix A, Section 2.8 (e) (4).                                                       ,
: 10CFR26, Appendix A, Section 2.8 (e) (4).
On May 28,-1993, a blind urine sample positive for Amphetamine was reported negative by the laboratory (Roche Biomedical Laboratories, Raritan, New Jersey).
On May 28,-1993, a blind urine sample positive for Amphetamine was reported negative by the laboratory (Roche Biomedical Laboratories, Raritan, New Jersey).
Roche Biomedical Laboratory was advised and promptly investigated the matter.       The results of that investigation are summarized in                 ;
Roche Biomedical Laboratory was advised and promptly investigated the matter.
i the reference letter attached.
The results of that investigation are summarized in i
the reference letter attached.
Should you have any questions, please do not hesitate to call.
Should you have any questions, please do not hesitate to call.
Sincerely, l                                                                                 ,
Sincerely, l
              . M. Hill
. M.
;            Resident Manager Shoreham Nuclear Power Station                                                     _
Hill Resident Manager Shoreham Nuclear Power Station LMH/RWG/mmd Enclosure (1) cc:
LMH/RWG/mmd Enclosure (1) cc:   Mr. Thomas T. . Martin                   Mr. R. Nimitz Regional Administrator                   Resident Inspector                     ,
Mr. Thomas T.. Martin Mr.
060005                                                                     y~' g 9307060334 930630 PDR   ADOCK 05000322-       Q ow                                                 ,
R. Nimitz Regional Administrator Resident Inspector 060005 y~'
b
g 9307060334 930630 Q
PDR ADOCK 05000322-ow b


j
j I
        .c Roche Biomedical                                                                                           I Laboratories e      a subsidiary of Hoffmann-La Roche Inc.                           Ikde Benedcal tatuatories.Inc.
.c Roche Biomedical Laboratories a subsidiary of Hoffmann-La Roche Inc.
09first Avenue in Dox500                               .
Ikde Benedcal tatuatories.Inc.
                                                                            . Ilantan.NewJersey08809 2400               l
e 09first Avenue in Dox500
                                                                                                                        ?
. Ilantan.NewJersey08809 2400 l
(800)631-5250 June 2, 1993                                                       (70115?S 2400                           7 Dr. Kenneth Goetz Medical Review Officer LILCO Employee Health Center                                                                                 :
?
100 East Old Country Road                                                                                     '
(800)631-5250 June 2, 1993 (70115?S 2400 7
Hicksville, NY 11801
Dr. Kenneth Goetz Medical Review Officer LILCO Employee Health Center 100 East Old Country Road Hicksville, NY 11801


==Dear Dr. Goetz,==
==Dear Dr. Goetz,==
Thank you for your phone call on Tuesday, June 1, alerting me to a .                                       'I potential false negative result for specimen number 148.-718-0178.                                         .;
'I Thank you for your phone call on Tuesday, June 1, alerting me to a.
i Based upon our discussion and at your written. request, I had the sample re-analyzed as' part of my investigation.                                       The results-         ,
potential false negative result for specimen number 148.-718-0178.
obtained upon repeat screening indicated.the presumptive presence                                             i i
i Based upon our discussion and at your written. request, I had the sample re-analyzed as' part of my investigation.
of an amphetamine compound. An amended report will be generated _
The results-obtained upon repeat screening indicated.the presumptive presence i
upon completion of testing.                                                                                 j My         investigation               lead me to     conclude   that       the       technologist       -[
of an amphetamine compound.
performing the secondary FPIA rescreening handled the-incorrect                                               -
An amended report will be generated _
aliquot.
i upon completion of testing.
l Corrective action will consist of a second verification of aliquots required for secondary rescreening against the internal aliquot                                             i chain of custody worklist.                       All staff have been met with and j
j My investigation lead me to conclude that the technologist
appropriately counselled.
-[
If I can be of further assistance or should you require any                                                 I additional actions, please do not' hesitate to contact me at (800) 631-5250, X-2225.                                                                                   :l Sincerely,                                                                                                   ;
performing the secondary FPIA rescreening handled the-incorrect aliquot.
i I
l Corrective action will consist of a second verification of aliquots required for secondary rescreening against the internal aliquot i
oseph P. Watson, M.S.
chain of custody worklist.
Laboratory Administrator,                                                                                   i Forensic Toxicology                                                                                 ,.
All staff have been met with and appropriately counselled.
h.
j I
If I can be of further assistance or should you require any additional actions, please do not' hesitate to contact me at (800) 631-5250, X-2225.
:l Sincerely, i
I oseph P. Watson, M.S.
Laboratory Administrator, i
Forensic Toxicology h.
JPW:akt
JPW:akt
    .            -. -_                        -                                            _ . . - .}}
-}}

Latest revision as of 11:16, 19 December 2024

Forwards Roche Biomedical Labs Reporting Unsatisfactory Performance Testing Result,As Part of fitness-for-duty Program.Blind Urine Sample Tested Positive for Amphetamine & Reported Negative by Lab
ML20045F030
Person / Time
Site: Shoreham File:Long Island Lighting Company icon.png
Issue date: 06/30/1993
From: Leslie Hill
LONG ISLAND POWER AUTHORITY
To:
NRC OFFICE OF INFORMATION RESOURCES MANAGEMENT (IRM), Office of Nuclear Reactor Regulation
References
LRM-93-068, LRM-93-68, NUDOCS 9307060334
Download: ML20045F030 (2)
v • d • e


Text

.

~'

Long Shoreham Nuclear Power Station l

Island P.O. Box 628 I

gg Power North Country Road N f/r Authority Wading River, N.Y.11792 l

LRM-93-068 i

June 30, 1993 U.

S. Nuclear Regulatory Commission

~r Document Control Desk Washington, D.

C.

20555

}

F Attention:

Office of NRR Division of Reactor Inspection and Safeguards

Subject:

Fitness for Duty Program-Shoreham Nuclear Power Station Unsatisfactory Performance Testing Result

Reference:

Letter Roche Biomedical Laboratories (JP Watson) to Dr.

K. Goetz dated 6/2/93

Dear Sir:

This notification is being sent in accordance with

10CFR26, Appendix A, Section 2.8 (e) (4).

On May 28,-1993, a blind urine sample positive for Amphetamine was reported negative by the laboratory (Roche Biomedical Laboratories, Raritan, New Jersey).

Roche Biomedical Laboratory was advised and promptly investigated the matter.

The results of that investigation are summarized in i

the reference letter attached.

Should you have any questions, please do not hesitate to call.

Sincerely, l

. M.

Hill Resident Manager Shoreham Nuclear Power Station LMH/RWG/mmd Enclosure (1) cc:

Mr. Thomas T.. Martin Mr.

R. Nimitz Regional Administrator Resident Inspector 060005 y~'

g 9307060334 930630 Q

PDR ADOCK 05000322-ow b

j I

.c Roche Biomedical Laboratories a subsidiary of Hoffmann-La Roche Inc.

Ikde Benedcal tatuatories.Inc.

e 09first Avenue in Dox500

. Ilantan.NewJersey08809 2400 l

?

(800)631-5250 June 2, 1993 (70115?S 2400 7

Dr. Kenneth Goetz Medical Review Officer LILCO Employee Health Center 100 East Old Country Road Hicksville, NY 11801

Dear Dr. Goetz,

'I Thank you for your phone call on Tuesday, June 1, alerting me to a.

potential false negative result for specimen number 148.-718-0178.

i Based upon our discussion and at your written. request, I had the sample re-analyzed as' part of my investigation.

The results-obtained upon repeat screening indicated.the presumptive presence i

of an amphetamine compound.

An amended report will be generated _

i upon completion of testing.

j My investigation lead me to conclude that the technologist

-[

performing the secondary FPIA rescreening handled the-incorrect aliquot.

l Corrective action will consist of a second verification of aliquots required for secondary rescreening against the internal aliquot i

chain of custody worklist.

All staff have been met with and appropriately counselled.

j I

If I can be of further assistance or should you require any additional actions, please do not' hesitate to contact me at (800) 631-5250, X-2225.

l Sincerely, i

I oseph P. Watson, M.S.

Laboratory Administrator, i

Forensic Toxicology h.

JPW:akt

-

Retrieved from "https://kanterella.com/w/index.php?title=ML20045F030&oldid=4525437"